Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

18.47
+0.69003.88%
Post-market: 18.470.00000.00%19:30 EDT
Volume:2.30M
Turnover:42.38M
Market Cap:2.36B
PE:-45.92
High:18.69
Open:17.99
Low:17.94
Close:17.78
52wk High:20.05
52wk Low:7.07
Shares:128.00M
Float Shares:117.00M
Volume Ratio:1.05
T/O Rate:1.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:3.01
PE(LYR):-21.90

Loading ...

Positive Report for Neo Performance Materials Inc (NEO) from Jefferies

TIPRANKS
·
Sep 26

Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)

TIPRANKS
·
Aug 27

NeoGenomics RaDaR ST Gains Expanded Medicare Coverage for Immunotherapy Response Monitoring

Reuters
·
Aug 27

Neogenomics Receives Medicare Coverage for Radar St for Immunotherapy Treatment Response Monitoring

THOMSON REUTERS
·
Aug 27

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.
·
Aug 26

NeoGenomics Inc. Earnings Call Signals Strong Clinical Push

TIPRANKS
·
Aug 15

NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing

TIPRANKS
·
Aug 15

Stifel Nicolaus Keeps Their Buy Rating on Neo Performance Materials Inc (NEO)

TIPRANKS
·
Aug 12

NeoGenomics Announces Planned Transition of General Counsel Role

TIPRANKS
·
Aug 12

NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion

TIPRANKS
·
Aug 08

NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400

Reuters
·
Aug 07

Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion

TIPRANKS
·
Aug 06

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

Simply Wall St.
·
Aug 06

Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales

Reuters
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

NeoGenomics (NEO) Stock Rallies As Profit Returns And Margins Improve

Simply Wall St.
·
Jul 30

Update: NeoGenomics Shares Rise After Q2 Beat

MT Newswires Live
·
Jul 30

NeoGenomics price target raised to $19 from $17 at Craig-Hallum

TIPRANKS
·
Jul 29

Needham Raises Price Target on NeoGenomics to $19 From $15, Keeps Buy Rating

MT Newswires Live
·
Jul 29